




Please do not adjust margins 
Please do not adjust margins 
Received 00th January 20xx, 
Accepted 00th January 20xx 
DOI: 10.1039/x0xx00000x 
 
Synthesis, Characterization and Photoinduced CO Release by 
Manganse(I) Complexes 
André L. Amorima,†, Ana Guerreirob,†, Vinícius A. Glitza, Daniel F. Coimbraa, Adailton J. Bortoluzzia, 
Giovanni F. Caramoria, Antonio L. Bragaa, Ademir Nevesa, Gonçalo J. L. Bernardesb,c,* and Rosely A. 
Peraltaa,* 
Herein, we report the CO-release activity of three new photoCORMs, two with nonbonding pyridine moieties and one with 
a benzyl group. The compounds [MnBr(CO)3(bpa-κ2)] (2, where bpa = N-benzyl(2-pyridylmethyl)amine); [MnBr(CO)3(pmpea-
κ2)] (3, where pmpea = N-(2-pyridylmethyl)-N’-(2-pyridylethyl)amine) and [MnBr(CO)3(bpea-κ2)] (4, where bpea = N-bis(2-
pyridylethyl)amine) were synthesized and characterized by common spectroscopic techniques (UV-Vis, IR). Density 
functional theory studies were also performed to provide new insights into the M–C bond and to assume the orbitals 
involved in the absorption transitions. Their CO-release activities were measured both in organic and in physiological media 
and compared to that of a previously published compound [Mn(CO)3(dpa-κ3)]Br (1, where dpa = N-bis(2-
pyridylmethyl)amine). An increase in the number of members of the chelate from five to six, influenced the release of CO, 
affecting both the binding mode of the ligand and the CO-release process and affecting their potential use as potentials CO 
release carriers as therapeutic agents.
Introduction 1 
The discovery of signaling molecules that can control biological 2 
functions has opened many possibilities in the fields of 3 
medicinal and bioinorganic chemistry. Although nitric oxide is 4 
among the most prominent signaling molecules,1 in recent 5 
years carbon monoxide has also been recognized as a signaling 6 
molecule in biological media.2–4 The cytotoxic effects are widely 7 
known,5 but carbon monoxide can also act in vital physiological 8 
processes, such as the regulation of ion-channels, and as a 9 
neurotransmitter, inhibitor of platelet coagulation and 10 
suppressor of acute hypertension.6–8 11 
 The controlled delivery of exogenous carbon monoxide has 12 
been used to protect against lung injury in vivo, as an anti-13 
inflammatory agent, to trigger cell apoptosis and to promote 14 
antioxidant activity.9–12 All of these properties support the use 15 
of CO as a versatile agent in medicinal chemistry. However, the 16 
high affinity of carbon monoxide for hemoglobin poses both a 17 
problem and a risk in relation to its use in high concentrations. 18 
Therefore, the development of new compounds that avoid the 19 
drawbacks of exogenously applied CO13 and that have the 20 
capacity to deliver carbon monoxide in a controlled manner is 21 
highly desirable.14 In this regard, low-valence metal carbonyl 22 
compounds can serve as favourable vehicles to transport 23 
carbon monoxide, given their interesting spectroscopic 24 
properties and the wide array of ligand modifications that can 25 
influence the CO release activity. The metal centres most 26 
commonly studied as possible CORMs candidates include iron, 27 
rhenium, molybdenum and manganese.15–18 28 
 There are several ways to promote the release of CO from 29 
these molecules and photoexcitation is one of the preferred 30 
methods. The first photoCORMs synthesized only showed 31 
activity in the UV light range, which represents a drawback in 32 
biological studies due to the potentially mutagenic nature of UV 33 
light.19 To overcome this difficulty, some research groups have 34 
been using ligands that shift either the carbon monoxide MLCT 35 
or the intraligand bands towards lower energy to facilitate CO 36 
release at higher wavelengths.20,21 In this context, some 37 
advances using conjugated polypyridyls and conjugated imine 38 
groups and softer ligands have been made.22,23 39 
 Nevertheless, the literature still lacks information on 40 
modifications around the metal center, in which nonbonding 41 
moieties are used in the ligand framework, and their influence 42 
on CO-release activity.  43 
 Herein, we report three new manganese photoCORMs (Fig. 44 
1), one with a noncoordinating benzyl moiety (2) and two that 45 
have a nonbonding pyridine in the coordination sphere (3, 4). 46 
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 1 
Fig. 1 Representation of the structures of the manganese carbonyls used in this study. 2 
 Because photo-release studies were conducted on a 3 
custom-made LED apparatus and the CO release activity is 4 
highly dependent on the way incident light is focused, the 5 
compound [Mn(CO)3(dpa-κ3)]Br (1, where dpa = N-bis(2-6 
pyridylmethyl)amine), previously reported by Gonzalez,24 was 7 
revisited in the light of new insights and its photo-release 8 
capabilities were compared to those of the synthesized metal 9 
carbonyls. 10 
 The synthesis, characterization and evaluation of the 11 
biological activity of three new carbonyl compounds, 12 
[MnBr(CO)3(bpa-κ2)] (2, where bpa = N-benzyl(2-13 
pyridylmethyl)amine) and [MnBr(CO)3(pmpea-κ2)] (3, where 14 
pmpea = N-(2-pyridylmethyl)-N-amine) and [MnBr(CO)3(bpea-15 
κ2)] (4, where bpea = N-bis(2-pyridylethyl)amine) are also 16 
reported herein. The compounds were characterized by using 17 
standard techniques, such as IR, UV-Vis and X-ray spectroscopy 18 
and mass spectrometry. The stability and the CO release activity 19 
were monitored by using well-known methods previously 20 
described in the literature,9 and the modifications were 21 
accompanied on electronic absorption spectra at different 22 
wavelengths. 23 
Experimental Section 24 
General procedures 25 
Ligands dpa, bpa, pmpea and bpea were synthesized 26 
analogously to previously published procedures25–28 and their 27 
schematic representations are shown in Fig. 1. The reactants 28 
used for the synthesis of the ligands and complexes were 29 
purchased from Merck. The reagents benzaldehyde, 2-30 
aminomethylpyridine, 2-aminoethylpyridine, 2-31 
pyridylcarboxyaldehyde and 2-vinylpyridine were distilled 32 
under reduced pressured and stored in an appropriate flask 33 
under argon at low temperature before use. 34 
 35 
Synthesis of the organometallic compounds 36 
 The synthesis of compounds 1–4 was performed under an 37 
inert atmosphere with a conventional Schlenk apparatus and all 38 
solvents used in the reactions were purified prior to use by 39 
standard procedures. Previously published compound 40 
[Mn(CO)3(dpa-κ3)]Br (1) was synthesized according to the 41 
literature24 and used for comparison. For the preparation of 42 
[MnBr(CO)3(bpa-κ2)] (2), [MnBr(CO)3(pmpea-κ2)] (3) and 43 
[MnBr(CO)3(bpea-κ2)] (4), a solution containing 0.25 mmol of 44 
the ligand (bpa, pmpea or bpea) in 10 mL of diethyl ether was 45 
degassed applying two freeze-pump-thaw cycles. The 46 
manganese precursor [MnBr(CO)5] (0.25 mmol) was added to a 47 
frozen solution of the ligand and the solution was thawed once 48 
more. The resulting solution stirred until the mixture reached 49 
room temperature. It was then heat to reflux under an inert 50 
atmosphere and dim light conditions for 12 h. The solvent was 51 
removed from the resulting solution under reduced pressure, 52 
providing a yellow solid. Crystals suitable for X-ray analysis were 53 
obtained by slow diffusion of hexane in a dichloromethane 54 
solution. 55 
 56 
[Mn(CO)3(dpa-κ3)]Br (1): pale yellow solid, yield: 74 mg; 418.12 57 
g mol-1, 71%. Selected IR frequencies (ATR, cm-1): 2025 (s, νCO), 58 
1935 (s, νCO), 1910 (s, νCO), 1605-1435 (w, νar), 760 (m, δar), 630 59 
(m, δar). Selected electronic absorption wavelengths (CH2Cl2, 60 
λmax in nm) and their respective ε values (L mol-1 cm-1): 350 61 
(2407), 300 (4250), 268 (4700), 244 (8019). MS (CH3CN, ESI, 62 
m/z): 338 [Mn(CO)3(dpa- k2)]+. Elemental analysis for 63 
(C15H13N3O3MnBr + H2O) (calculated in parenthesis): C, 42.52 64 
(41.31); H, 3.37 (3.47); N, 9.70 (9.63). 65 
 66 
[MnBr(CO)3(bpa-κ2)] (2): pale yellow solid, yield: 78 mg; 416.15 67 
g mol-1, 75%. Selected IR frequencies (ATR, cm-1): 2019 (s, νCO), 68 
1914 (s, νCO), 1611-1437 (w, νar), 764 (m, δar), 627 (m, δar). 69 
Selected electronic absorption wavelengths (CH2Cl2, λmax in nm) 70 
and their respective ε values (L mol-1 cm-1): 380 (1423), 322 71 
(1840). Elemental analysis for (C16H14N2O3MnBr + H2O) 72 
(calculated in parenthesis): C, 43.65 (44.16); H, 3.46 (3.71); N, 73 
6.34 (6.44). 74 
 75 
[MnBr(CO)3(pmpea-κ2)]Br (3): yellow solid, yield: 68 mg; 432.15 76 
g mol-1, 63%. Selected IR frequencies (ATR, cm-1): 2020 (s, νCO), 77 
1910 (s, νCO), 1605-1385 (w, νar), 770 (m, δar), 630 (m, δar). 78 
Selected electronic absorption wavelengths (CH2Cl2, λmax in nm) 79 
and their respective ε values (L mol-1 cm-1): 355 (2078), 288 80 
(4525), 253 (6927). MS (CH3CN, ESI, m/z): 352 [Mn(CO)3(pmpea-81 
κ3)]+. Elemental analysis for (C16H15N3O3MnBr) (calculated in 82 
parenthesis): C, 43.87 (44.47); H, 3.37 (3.50); N, 9.62 (9.72). 83 
 84 
[Mn(CO)3(bpea-κ2)]Br (4): yellow solid, yield: 64 mg; 446.18 g 85 
mol-1, 58%. Selected IR frequencies (ATR, cm-1): 2020 (s, νCO), 86 
1905 (s, νCO), 1605-1380 (w, νar), 760 (m, δar), 630 (m, δar). 87 
Selected electronic absorption wavelengths (CH2Cl2, λmax in nm) 88 
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and their respective ε values (L mol-1 cm-1): 370 (1903), 298 1 
(4561), 269 (7908). MS (CH3CN, ESI, m/z): 366 [Mn(CO)3(bpea-2 
κ3)]+. Elemental analysis for (C17H17N3O3MnBr) (calculated in 3 
parenthesis): C, 45.15 (45.76); H, 3.76 (3.84); N, 9.28 (9.42). 4 
 5 
Physical Measurements 6 
IR spectra were obtained with a PerkinElmer Spectrum 100 7 
FT-IR spectrophotometer with an ATR unit. Electrospray 8 
ionization-mass spectrometry (ESI-MS) was carried on an 9 
Amazon-Ion Trap mass spectrometer in acetonitrile with an 10 
approximate concentration of 500 ppb. Electronic absorption 11 
spectra were obtained on a Varian Cary 50 UV-Vis 12 
spectrophotometer in quartz cuvettes of 1 cm path length. NMR 13 
spectroscopy was carried out with a Bruker Ascend 400 Varian 14 
FT-NMR 400 MHz setup using CDCl3 as the solvent, at 25 °C. 15 
Chemical shifts were referenced to tetramethylsilane (TMS, δ = 16 
0.00 ppm). 17 
 18 
Single-Crystal X-ray Structure Determinations 19 
 Crystallographic analysis of compounds 1, 3, and 4 was 20 
carried out with a Bruker APEX II DUO diffractometer wit 21 
graphite-monochromated Mo-Kα radiation (λ = 0.071069 nm) at 22 
200(2). Images were recorded by using the φ and ω scan 23 
method.29 All intensities were corrected for Lorentz polarization 24 
effects and for absorption. The structures were solved by direct 25 
methods and refined by the full matrix least-squares methods 26 
using the SHELX program.30 H atoms attached to C atoms were 27 
placed at their idealized positions, with C–H distances and Ueq 28 
values takes from the default settings of the refinement 29 
program. Hydrogen atoms of the amine groups were found on 30 
a Fourier difference map and treated as free atoms. ORTEP plots 31 
were drawn with the PLATON program.31 Full crystallographic 32 
tables (including structure factors) for complexes 1, 3 and 4 33 
have been deposited with the Cambridge Crystallographic Data 34 
Centre under supplementary publication numbers CCDC 35 
1824854-1824856. These data can be obtained free of charge 36 
from the Cambridge Crystallographic Data Centre at 37 
www.ccdc.cam.ac.uk. 38 
 39 
Computational Methods 40 
 Initially geometries for all compounds were obtained by 41 
using DFT32,33 with the BP8634 exchange correlation functional 42 
and Grimme’s D3BJ dispersion correction35 along with the 43 
Ahlrich basis sets36–38 as implemented in the Orca package, 44 
version 3.0.2.39 Structures were confirmed as minima by the 45 
absence of imaginary eigenvalues in the generalized Hessian 46 
matrix. 47 
 Kohn-Sham energy decomposition analysis (GKS-EDA), 48 
implemented in GAMESS-US 2012,40 and the same protocols 49 
described for the geometry optimizations. The Boys and 50 
Bernardi approach41 was used to correct for basis set 51 
superposition errors. In all cases a CO ligand was considered as 52 
one (neutral) fragment whereas the remainder of the molecule 53 
was the second fragment without residual charges. The GKS-54 
EDA scheme decomposes the instantaneous interaction energy 55 
(ΔEint) into the sum of six physical meaningful terms: 56 
electrostatic (ΔEelstat), exchange (ΔEexch), repulsion (ΔErep), 57 
polarization (ΔEpol), dispersion (ΔEdisp) and correlation (ΔEcorr). 58 
 Absorption spectra of all compounds were obtained by 59 
using TD-DFT42 and the same protocol described above, but 60 
with the B3LYP functional43, 44 and the SMD solvation model.45 61 
 62 
Cell culture 63 
 Two different cell lines were used for the in vitro studies, 64 
namely, HepG2 (a human hepatoma cell line) and HeLa cells 65 
(derived from cervical cancer cells). The cells were maintained 66 
in a humidified incubator at 37 °C in 5% CO2 and grown in 1x 67 
Dulbecco’s modified Eagle medium (D-MEM) with sodium 68 
pyruvate and without L-glutamine (Invitrogen, Life 69 
Technologies) supplemented with 10% heat-inactivated fetal 70 
bovine serum (FBS) (Gibco, Life Technologies), 1x MEM NEAA 71 
(Gibco, Life Technologies), 1X GlutaMAX (Gibco, Life 72 
technologies), 200 units mL-1 penicillin and 200 μg mL-1 73 
streptomycin (Gibco, Life Technologies) and 10 mmol L-1 HEPES 74 
(Gibco, Life Technologies). 75 
 76 
Cell viability assay 77 
 A total of 104 cells per well were seeded in 96-well plates 78 
and treated with either 1–4, 24 h after the seeding, to allow the 79 
cells to stabilize. The cells were incubated with 1, 5, 10, 25, 50, 80 
100 and 150 μmol L-1 of the carbonyl compounds for 24 h. After 81 
this incubation period, the culture medium was removed and 82 
the cells were incubated with CellTiter-Blue (Promega) for 90 83 
min at 37 °C. The cell viability was evaluated by measuring the 84 
emission intensity in relative fluorescent units (RFUs) with an 85 
Infine M200 plate reader. After the reading, the cells were re-86 
incubated with the complexes for an additional period of 24 h, 87 
giving a total incubation time of 48 h. The cell viability assay was 88 
performed as mentioned above for 24 h time point. 89 
 90 
CO release in aqueous solution 91 
 The CO release profiles for compounds were determined in 92 
aqueous solution by COP-1 fluorescence,46 at different time 93 
points (0, 10, 20, 30, 40, 50, 60, 70, 80 and 90 min). The COP-1 94 
fluorescence was measured in the absence (negative control) 95 
and presence of 150 μmol L-1 of 1-4 using an Infinite M200 plate 96 
reader. The compounds were mixed with a 1 μmol L-1 solution 97 
of COP-1 (in PBS pH 7.4) previously prepared from a 5 μmol L-1 98 
stock solution of COP-1 in DMSO. The COP-1 was synthesized 99 
according to a procedure described in the literature.46 The 100 
measurements were taken in the range 490–610 nm. 101 
 102 
CO release in cells measured by confocal microscopy 103 
 A total of 304 HeLa cells per well were seeded 24 h prior to 104 
the experiment in an 8-chambered lbidi cell plate with a 105 
medium containing reduced phenol red. Thirty minutes before 106 
incubation with the carbonyl compounds, the cells were 107 
incubated with a 1:2000 dilution on Syto61 (Lyfe Technologies), 108 
washed with the medium and finally incubated with 150 μmol 109 
L-1 of compounds 1, 3 and 4. Throughout the experiment the 110 
cells were maintained at 37 °C in 5% CO2. Images were obtained 111 
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by using a Zeiss LSM 710 confocal Laser Point-Scanning 1 
Microscope with a 40X oil objective lens and a numerical 2 
aperture of 1.3. COP-1 was added and excited with an argon 3 
laser with a wavelength of 488 nm, whereas Syto61 was excited 4 
using a DPSS 561-10 laser (561 nm). COP-1 was read in the green 5 
range (500-550 nm) and Syto61 in the red range (570-640 nm). 6 
The mean total fluorescence intensities of treated and 7 
untreated cells were determined with the help of ImageJ 8 
software. Statistically significant difference was tested by 9 
applying the Mann Whitney test. Data are presented in the 10 
graphs as the mean total fluorescent intensity ± SEM. 11 
RESULTS AND DISCUSSION 12 
Synthesis and powder characterization 13 
 The ligands dpa, bpa and pmpea were prepared by 14 
reduction of the Schiff-base formed in the condensation 15 
reaction of 2-pyridylcarboxyaldehyde and the selected primary 16 
amines.26–28 The ligand bpea was synthesized through the 17 
reduction of the hydroxylamine formed by the reaction 18 
between 2-vinylpyridine and ammonium hydroxide.25 The 19 
carbonyl compounds 1–4 were synthesized analogously to the 20 
parent compound 1,24 but using diethyl ether as solvent, which 21 
was used as reference to study the effect of nonbonding moiety 22 
(compound 2) and the increase in the number of chelate 23 
members (compounds 3 and 4) from five to six. 24 
 The carbonyl compounds synthesized showed two major CO 25 
stretching bands: a narrow band around 2025 cm-1 (symmetrical 26 
νCO) and a broader high intensity band around 1970-1900 cm-1 27 
(double degenerate asymmetrical νCO). This indicates that all 28 
three systems deviate from the C3v symmetry, either as a result 29 
of asymmetry of the first coordination sphere (compounds 2-4) 30 
or to the presence of water and the formation of hydrogen 31 
bonds (compound 1). These results are in agreement with 32 
typical CO stretching bands, which adopt a distorted facial 33 
coordination.47,48 The spectra for compounds 1-4 are shown in 34 
Fig. S1-S4. 35 
 The powders of compounds 1-4 showed good stability in the 36 
absence of light, but compounds 2-4 showed some thermal 37 
decomposition under the experimental conditions of the 38 
elemental analysis, since these two compounds a decrease in 39 
the carbon content relative to the calculated percentage (from 40 
43.87 to 44.47 and from 45.15 to 45.76, respectively). 41 
Crystal structures 42 
 Compounds 1, 3 and 4 were crystallized by slow diffusion of 43 
hexane into a dichloromethane solution at 25 °C that gave 44 
yellow crystals. Unfortunately, crystallization of 2 yielded 45 
crystals with low refractive index, which resulted in poor 46 
resolution. 47 
 The structure of 1 is similar to that published by Gonzalez 48 
and co-workers.24 However, the crystal data obtained in this 49 
study differ, both in terms of the crystal structure and the space 50 
group, and are therefore reported herein. A striking difference 51 
between the structures is the presence of a water molecule in 52 
the lattice obtained in this study, which interacts with the 53 
uncoordinated bromide and a hydrogen atom of a methylene 54 
group, originating hydrogen bonds of 239 and 233 pm, 55 
respectively. This interaction directly influences one of the 56 
pyridine moieties, increasing the Mn1-N2 bond, when 57 
compared to the Mn1-N3 bond. Selected bond lengths of 1 are 58 
listed in Table 1 and full tables of these geometric structural 59 
parameters can be found in the Supplementary Information 60 
material. ORTEP plots of compounds 1, 3 and 4 are shown in Fig. 61 
2. 62 
 The structures of 3 and 4, have some similarities with that 63 
of compound 1. The increase in the chelate members furthers 64 
distorts the geometry, passing to a monoclinic crystal system 65 
and a C2/c space group for 3 and a triclinic crystal system and a 66 
P-1 space group for 4. Moreover, as can be seen by the crystal 67 
structures obtained, the mild conditions employed in the 68 
synthesis procedure did not displace the bromide coordinated 69 
to the manganese center, resulting in an uncoordinated 70 
pyridine group, which can have profound effects in the CO 71 
release activity. Similar results were already reported by our 72 
group.49 The bonds and angles are summarized in Table 1 and 73 
are compatible with values described in the literature for similar 74 
tricarbonyl compounds.50,51 75 
 76 
Table 1. Selected bond lengths (Å) and angles (degrees) of 1, 3 and 4. 
Bond lengths of compound 1 (Å) 
Mn1-C1 1.809(2) Mn1-N1 2.0724(18) 
Mn1-C2 1.803(2) Mn1-N2 2.0624(16) 
Mn1-C3 1.813(2) Mn1-N3 2.0572(15) 
Bond angles of compound 1 (degrees) 
C1-Mn1-C2 88.26(9) C1-Mn1-N2 93.10(8) 
C1-Mn1-C3 88.27(10) C1-Mn1-N3 98.23(8) 
C1-Mn1-N1 173.10(8)   
Bond lengths of compound 3 (Å) 
Mn1-C1 1.803(3) Mn1-N1 2.101(2) 
Mn1-C2 1.803(3) Mn1-N2 2.049(2) 
Mn1-C3 1.849(3) Mn1-Br1 2.5238(4) 
Bond angles of compound 3 (degrees) 
C1-Mn1-C2 88.48(13) C1-Mn1-N2 94.50(10) 
C1-Mn1-C3 90.27(11) C1-Mn1-Br1 90.37(8) 
C1-Mn1-N1 175.35(10)   
Bond lengths of compound 4 (Å) 
Mn1-C1 1.811(2) Mn1-N1 2.1269(14) 
Mn1-C2 1.8044(19) Mn1-N14 2.11117(13) 
Mn1-C3 1.8002(19) Mn1-Br1 2.5273(3) 
Bond angles of compound 4 (degrees) 
C2-Mn1-C1 85.25(9) C2-Mn1-N14 92.58(7) 
C1-Mn1-C3 90.32(8) C2-Mn1-Br1 90.64(6) 
C2-Mn1-N1 174.76(7)   
 77 
Full crystallographic tables (including structure factors) for 78 
1, 3 and 4 have been deposited with the Cambridge 79 
Crystallographic Data Centre under supplementary publication 80 
numbers CCDC 1824854-1824856. These data can be obtained 81 
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free of charge from the Cambridge Crystallographic Data Centre 1 
at www.ccdc.cam.ac.uk. 2 
Fig. 2 ORTEP plots for the compounds with atom labeling; (a) compound 1; (b) compound 3 and (c) compound 4. Ellipsoids are drawn at 40% probability level. The water molecule 
and bromide in 1 as well as the hydrogen atoms have been omitted for clarity.
Gas-phase calculations and energy 
decomposition analysis 
 
 Generalized Kohn-Sham energy decomposition analysis 
(GKS-EDA) was conducted in order to gain insight into the effect 
of the first coordination sphere on the Mn-CO bonding energies 
and to understand why the bromide remained coordinated to 
the metal center under the mild conditions employed in the 
synthesis. 
 As a starting point, the crystal data were used for the 
geometry optimizations, resulting in structures with no 
imaginary frequencies. The theoretical CO stretching bands thus 
obtained show a good correlation with the experimental values, 
as can be seen in Table S1. Moreover, the theoretical results 
prove that compound 1, which has a higher symmetry, adopts a 
k3 binding mode and has only two CO stretching frequencies, 
whereas the remainder have three CO stretching frequencies, 
reinforcing the κ2 binding mode of these compounds. 
 The calculated interaction energies (ΔEint) obtained from the 
EDA analysis are directly related to the dissociation energy of 
the carbonyls, which reflects how the ligand framework 
stabilizes the M-C bonds. Compound 1 shows a high degree of 
symmetry and all three M-CO bonds have interaction energies 
of -44.77, -43,98 and -43,95 kcal mol-1, respectively, which 
shows that both the secondary amine and the pyridines 
contribute equally to the stabilization of the carbonyl ligands. 
 The substitution of a pyridine moiety by a bromide in the 
first coordination sphere increases the interaction energy for 
the M-CO bonds trans to the pyridine and the amine moieties 
by 2 and 4 kcal mol-1 respectively. However, this increase in the 
interaction energies is more than compensated by the decrease 
of the M-CO bond energy trans to the bromide unity, which 
shows a decrease of approximately 7 kcal mol-1 (around -52 kcal 
mol-1). 
 This steep decrease in energy is consistent with the use of σ 
donating ligands in this type of compound. Overall, these values 
verify that ligands with a donating character, such as the 
bromide, promote stabilization of the M-CO bond. This is one of 
the reasons why mild reaction conditions do not favor the 
displacement of the bromide and further coordination of the 
pyridine moieties. 
Determination of the active species in solution 
 Because of the elusive coordination mode of 3 and 4, where 
the pyridine moiety in nonbonded, the determination of the 
active species in solution is essential to gain an insight into the 
stability of these photoCORMs. In this regard, the changes in the 
metal to ligand charge transfer (MLCT) at  »350–400 nm region 
can reflect the changes in the first coordination sphere of the 
compounds. 
 For this reason, the changes in the UV spectra of 1-4 were 
monitored for 12 h in the dark in a noncoordinating solvent 
(dichloromethane) and in a coordinating solvent (acetonitrile) 
solvent, water was not used because of the lower solubility of 
the neutral compounds 2-4 in this media and the high 
concentrations needed to attain good quality spectra. The 
spectrum of compound 1 remains unchanged for both solvents 
during the analysis (Fig. 3a) with MLCT bands at 354 and 350 nm 
for dichloromethane and acetonitrile respectively, which 
indicates that 1 does not undergo any configurational change 
and has good stability in both media during the analysis. 
 In dichloromethane solution, compounds 2-4 did not show 
changes in the MLCT bands over time, so retained their initial 
values of 380, 379 and 379 nm, respectively. Changing the 
solvent to acetonitrile, a hypsochromic shift with clear 
isosbestic points was detected, as seen in Fig. 3b for 4, (Fig. S5 
for 2 and S6 for 3) with displacements of the absorption bands 
to 363, 364 and 368 nm, for 2-4, respectively. This behavior 
could be due either to the replacement of the bromide by 
acetonitrile, or to the bonding of the pyridine moieties for 
compounds 3-4. 
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Fig. 3 Normalized UV spectra of 1 (a) and 4 (b) in dichloromethane (solid line) and 
acetonitrile initial (dashed line) and after 12 h incubation (dotted line). 
 This change in the primary coordination sphere could also 
be detected by IR spectroscopy, where the substitution of the 
bromide by a higher field ligand, in this case acetonitrile, shifts 
the symmetric CO stretching towards higher energy. However, 
as can be seen by the shifts of the IR spectra (Fig. 4a for 1, 4b 
for 4, S7 for 2 and S8 for 3), the extent of the displacement is 
quite different for each compound. 
In compound 2, the changes in the symmetrical νCO, from 
2025 to 2044 cm-1, showed that only minor amounts of the 
initial compound that contains the bromide in the first 
coordination sphere are exchanged by acetonitrile. This 
hypothesis is corroborated by the absence of characteristic ESI-
MS peaks, and the poor ionization of the sample (only 
background noise was detected). Moreover, the shift of the 
symmetrical νCO is compatible with the calculated values (Table 
S1) of the acetonitrile bound compound, as well as values 
reported by other groups for similar compounds.50 For this 
reason, it is feasible to believe that 2 undergoes, to some 
extent, displacement of the bromide forming species 2s, as 
shown in Fig. 5. 
Fig. 4 Changes in the IR spectra of 1 (a) and 4 (b) in dichloromethane (solid line) and 
acetonitrile (dashed line) after the incubation period of 12h. 
The IR spectra of 3 and 4 (Fig. S8 and 4b) display a higher 
degree of shift, with a displacement of the symmetrical νCO, 
from 2020 to 2030 and 2023 to 2036 cm-1 for 3 and 4, 
respectively. Comparison of the symmetrical νCO shifts for 2-4, 
make it clear that the species formed in 2 is somewhat different, 
because there is a 10 cm-1 difference. This could be due to the 
bonding of the nonbonded pyridine moiety, forming k3 
compounds, forming 3py-4py, as soon as 3s-4s are formed, as 
depicted in Fig. 5. 
 
  
Fig. 5 Proposed species formed in solution of the photoCORMs 2-4. 
Moreover, although 3 showed two equal intensity peaks, 4 
had a complete displacement of the band to higher energy. In 
addition, it is apparent from the spectra a gain in symmetry 
observed by the lesser degree of splitting of the degenerate 
stretching bands. 
Another proof of this mechanism was obtained by 
comparing the theoretical and experimental values of the λmax 
and νCO (Table S1), for all the possible species formed during the 
incubation period. These calculated values are consistent with 
the experimental CO stretching values obtained for 2s and 3py-
4py. 
The formation of the pyridine bonded compounds was 
detected by ESI-MS (Fig. S9-S11), for which only one peak with 
a m/z higher than 10% intensity was detected, that is, at 352 
and 366 for 3py and 4py, respectively. This demonstrates that the 
nonbonding pyridines displace the coordinated solvent. Several 
attempts were made to obtain the mass spectra of 3s-4s, 
however, these bonded acetonitrile compounds seem to have a 
short lifetime after the ionization process, and no fragments 
relative to these species were found. 
These results are in agreement with the proposed 
mechanism of compounds like [MnBr(CO)3(L)], in which L is a 
bidentate ligand,22,52 where a solvent molecule displaces the 
coordinated bromide in coordinating solvents. This would also 
explain the solubility of 2-4 in aqueous media, due to the 
formation of cationic compounds. 
Specifically for 3s-4s, further displacement of the solvent by 
the nonbonded pyridine, is also reported in the literature for 
compounds that adopt a κ2 binding mode, such as 
[Mn(CO)3(tpa- κ3N)]+ synthesized by Nagel and more recently 
the photoCORMs using the ligands κ2N1,N2 (2,6-
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hydroxyethyl)amino-benzyl-2,2ʹ:6ʹ,2ʺ-terpyridine).53, 54 These 
findings should help develop photoCORMS that can modulate 
the CO release process either by interaction with coordinating 
species that are either already part of the ligand, as in 3 and 4 
or that are present in the employed media, like solvent and 
species present only in biological studies. Changes in the 
coordination sphere are seldom explored and should help 
modulate the CO release activity by promoting changes in CO 
lability as well as in the photoexcitation wavelength. 
The NMR spectra of 1, 3, and 4 were collected at room 
temperature, which could provide valuable information on the 
binding mode and the possible displacement of the bromide by 
the solvent and subsequently by the pyridine moieties, could 
only be obtained in CDCl3, limiting the information obtained. 
The 1H NMR spectra (Fig. S12-S14) display several couplings 
between the hydrogen atoms mostly attributed to the 
conformational freedom of the nonbonding moiety, rendering 
the integration of the 1H NMR spectra difficult and the results 
inconclusive. 
Having knowledge of the active species in solution is 
essential to fine-tune the CO photorelease, because the λmax 
and consequently the excitation wavelength are dependent on 
the species formed. A better insight of the influence of the 
species in the triggering mechanism can be understood by 
analyzing the orbitals associated with the MLCT band. 
The major excitation attributed to the MLCT with fosc above 
0.01 are displayed in Fig. 6 for compound 3py and for 
compounds 1-4, 2s and 4py are shown in Fig. S15. As expected, 
the major singlet excitations attributed to the MLCT bands, 
which originate from HOMO to LUMO+1 orbitals and have 
characteristic πM-CO to the π*py transitions.22 Taking into 
consideration both the experimental and the theoretical results 
the changes in the first coordination sphere can modulate the 
excitation wavelength, and our results reinforce the concept 
that the s donating character contribute to bathochromic shifts 
of the MLCT and thereafter of the excitation wavelength. 
 
 
Fig. 6 Calculated frontier molecular orbital diagram of 3py. The most prominent MOs 
involved with transitions under the lower energy band and its energy diagram are shown. 
CO release studies 
The CO release activity was evaluated at four wavelengths 
ranges: red (630 ± 10 nm), green (530 ± 5 nm), blue (460 ± 5 nm) 
and violet (380 ± 10 nm). Since the title compounds do not show 
any absorption band above 400 nm, no modification of the UV 
spectra was observed upon exposure to red or green light and 
only minor modifications were detected upon irradiation with 
blue light. Thereafter, the CO release activity was only 
evaluated by excitation in the violet region (λ380), in both 
dichloromethane and in acetonitrile solution. 
All compounds showed solvent-dependent behaviors upon 
exposure to λ380. In dichloromethane, active species 1-4 
maintain their coordinating sphere and there is an exponential 
decrease in the MLCT absorption bands, which indicates the 
release of CO upon light exposure and results in clear solutions. 
However, with acetonitrile as solvent, active species 1, 2s, 3py 
and 4py show a concomitant increase in the baseline and 
decrease in the MLCT absorption bands, due to the formation 
of an oxide precipitate during the photolysis,47,55 leading to 
yellow to brown solutions. Both behaviors can be seen in Fig. 7 
for 4 and Fig. S16-S21 for 1-3. 
In both cases, the apparent CO release constants (rco) and 
the quantum yield (Φ) were determined by monitoring the 
intensity of the selected wavelength over time. All data show 
that the active species present a linear dependence between 
ln[C] and time. The data for all compounds in both solvents are 
summarized in Table 3. As expected, in acetonitrile the CO 
release leads to a lower decomposition rate, both to the 
formation of the oxide species during photoexcitation, and the 
hypsochromic displacement of the MLCT in CH3CN, either by 
coordination of the solvent or by the nonbonding moiety. 
Therefore, the quantum yield values cannot be trusted due 
to the interference of the formed precipitates with the incident 
light and due to dispersion of the absorption values, it was 
calculated only for compounds 1, 2 and 4 in the 
dichloromethane that presented a linear release. Furthermore, 
the CO release rate are coherent with the absorption bands 
observed for all compounds, where the fastest CO release was 
observed for compound 4, which has the largest bathochromic 
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Fig. 7 (a) Changes in the UV spectrum of 4 upon light irradiation (λ380) in 
dichloromethane; (b) Changes in the UV spectrum of 4py upon light irradiation (λ380) in 
acetonitrile. 
Table 3. Linearized constants and quantum yield for compounds 1-4. 
 CH2Cl2 CH3CN 
 rco (s-1) 10-3 λmax Φ rco (s-1) 10-3 λmax Φ 
1 2.3 ± 0.1 354 0.02 ± 0.01 1.0 ± 0.1 350 - 
2 4.0 ± 0.1 380 0.05 ± 0.01 3.0 ± 0.1 363 - 
3 3.0 ± 0.1 379 - 1.3 ± 0.1 364 - 
4 4.9 ± 0.1 379 0.06 ± 0.01 1.0 ± 0.1 368 -  
 
The photo-released products for the irradiated samples 
were also analyzed by KBr IR spectra (Fig. 8 for 4 and Fig. S22-
27 for 1-3). In dichloromethane the compounds lose the CO 
with no defined intermediate, in acetonitrile, all compounds 
form a third and lower intensity band around 1870-1850 cm-1, 
associated with the formation of a biscarbonyl 
intermediate.49,53,54,56 The relative low intensity of the 
biscarbonyl intermediate may be due to fast oxidation of the 
compounds once they begin to lose the CO, as previously 
reported.47,55 On comparing the relative areas after 
photoexcitation, all compounds lose all three CO molecules in 
both media. 
 
Fig. 8 (a) Changes in the IR spectrum of 4 upon light irradiation (λ380) in dichloromethane; 
and (b) Changes in the IR spectrum of 4py upon light (λ380) in acetonitrile. 
CO release in aqueous solution and living cells 
Having shown the potential photo-mediated CO release of 
compounds 1-4 in organic solutions, we next decide to evaluate 
CO release in physiological conditions, thus testing the 
compounds in aqueous solution and in cells. First, we 
determined their potential toxicity towards HeLa and HepG2 
cells. Briefly, cells were incubated with a range of 
concentrations from 1 to 150 μmol L-1 of 1-4 for 24 h and 48 h. 
At these time points, a slight decrease in the percentage of live 
cells compared to the untreated cells was observed in the case 
of compounds 1, 3 and 4, although the percentage was always 
higher than 70% (Fig. 9a and S29), which indicates low toxicity 
of the compounds even at high concentrations (150 μmol L-1). 
On the other hand, compound 2 promoted a strong decrease in 
cell viability, leading to as low as 10% of live cells after 48 h 
incubation, which is indicative of a higher toxicity effect. 
To quantify the CO release in aqueous solution we incubated 
the compounds with a phosphate buffered saline solution (PBS, 
pH 7.4) and used the turn-on fluorescent probe COP-1 for 
selective CO detection, because this probe emits a green 
fluorescence signal in the presence of CO.57 We observed that 
compounds 1, 3 and 4 indeed release CO in aqueous solution, 
being compound 1 the one that exhibits a stronger release. 
Conversely, compound 2 strongly affects cell viability, so its CO 
release is only 1.6x higher than the control (Fig. 9b). This might 
be explained by a potential slow release of CO that may not be 
detected by microscopy as soon as 60 min after incubation. 
Moreover, CO release was higher when the complexes were 
irradiated with light at a wavelength of 510 nm and increased 
with time of exposure to COP-1, as expected (Fig. S28). 
To further investigate the CO release potential of the 
compounds in biological conditions, HeLa cells were incubated 
with 150 μmol L-1 of compounds 1, 3 and 4, in the presence of 
COP-1. As compound 2 barely released CO in aqueous solution 
it was not included in these cell assays. The results show an 
increase in the COP-1 fluorescence in the presence of 
compounds 1 and 3, in a time-dependent manner, whereas 
compound 4 showed no difference over time relative to the 
control (cells with COP-1 only), which is in agreement with the 
CO release observed in aqueous solution (Fig. 9c and S30). 
Furthermore, we observed that CO release promoted by these 
molecules was associated with the perinuclear region of the 
cells (Fig. 9c), as previously reported.46 
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Fig. 9 CO release in aqueous solution and live cells. (a) Viability of HeLa and HepG2 cells 
after treatment with 150 μmol L-1 of compounds 1-4 for 24 h and 48 h. The results are 
shown as percentage of control (Mean + SEM of three biological replicates); (b) 
Histogram representing the emission intensity (RFUs – relative Fluorescent Units) 
measured at 60 min after incubation of 1 μM COP-1 (λex = 475 nm) with 150 μmol L-1 of 
either 1-4 in PBS pH 7.4 at 37 °C. The results are shown as fold increase relative to the 
control (Mean + SEM of three independent experiments); (c) Representative confocal 
microscopy images of CO release in live HeLa cells, untreated (control) and treated with 
150 μmol L-1 of compounds 1-4, 45 min after incubation with 1 μmol L-1 COP-1. Left panel 
– nucleic acid staining with Syto61 (red), middle panel – COP-1 turn-on response to CO 
(green), right panel – merged channel. Scale bar = 20 µm. 
CONCLUSION 
In recent years, CORMs have gained attention from several 
research groups that are trying to use these molecules as a CO 
carrier in biological systems, avoiding the drawbacks of 
exogenously applied CO. Trigger mechanism for the carbon 
monoxide release and the kinetic parameters are extensively 
described for several tricarbonyl compounds. In this study, 
three new manganese tricarbonyl compounds were synthesized 
and compared to the reference compound [Mn(CO)3(dpa)]Br. In 
our synthetic approach compounds 2-4 kept a κ2 binding mode, 
with a nonbonded pyridine group. This elusive binding mode 
was studied both in coordinating and noncoordinating solvents, 
which demonstrated that in coordinating solvents the bromide 
is replaced by a solvent molecule, which is further displaced by 
the nonbonded pyridine groups of 3 and 4, proved both by IR 
and UV spectroscopy. Moreover, the photoactivity of 
compounds 1-4, showed that the CO release activity was 
solvent dependent. In dichloromethane it was found that the 
linearized constants follow the trend rco4 > rco2 > rco3 > rco1 and 
the quantum yield Φ4 > Φ2 > Φ1, which are coherent with the 
bathochromic shifts of the MLCT bands. Where as in 
acetonitrile, the compounds formed an oxide precipitate, even 
so the IR spectra of the photoproducts show a complete release 
of carbon monoxide. During the in vitro study there is a shift in 
the CO release activity trend, as shown by the relative 
fluorescent unit (RFU) values obtained. The results of this study 
demonstrate that even small modifications to the ligand 
framework, such as an increase in the chelate members, can 
directly influence the carbon monoxide release kinetics, both in 
medium. 
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